Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 7/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 6/20 | 0.32 |
| ▸ | PMM2 | O15305 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24767800 | 0.97 | MAPK10 (0.34) | TOP2AMAPK10MAPK9PMM2MPI | |
| SCHEMBL24767801 | 0.92 | TOP2A (0.34) | TOP2A | |
| SCHEMBL24767783 | 0.86 | TOP2A (0.33) | TOP2A | |
| SCHEMBL24768833 | 0.86 | ATM (0.36) | TOP2A | |
| SCHEMBL18960866 | 0.86 | PMM2 (0.39) | MAPK10MAPK9PMM2MPIPHOSPHO1 | |
| SCHEMBL24768814 | 0.85 | TOP2A (0.31) | TOP2A | |
| SCHEMBL24768917 | 0.85 | CYP17A1 (0.36) | TOP2AMAPK10MAPK9MAPK8 | |
| SCHEMBL17246592 | 0.84 | CYP19A1 (0.36) | TOP2AMAPK10MAPK9PMM2MPI | |
| SCHEMBL24767791 | 0.84 | ALOX12 (0.34) | TOP2A | |
| SCHEMBL18748701 | 0.84 | PMM2 (0.36) | PMM2MPIPHOSPHO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | TOP2A 4331/4885MAPK10 2408/4885MAPK9 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.